View More Recent Stories

May 5, 2015 07:30AM Arrowhead Completes Dosing Healthy Volunteers and Initiates Transition to Patients in Phase 1 Study of ARC-AAT
May 4, 2015 04:01PM Arrowhead to Report Fiscal 2015 Second Quarter Financial Results
Apr 30, 2015 07:30AM Arrowhead Publishes Data on Advances in Subcutaneous siRNA Delivery
Apr 28, 2015 04:01PM Arrowhead to Present at Upcoming Conferences
Apr 13, 2015 07:30AM Arrowhead Cleared to Proceed with Multiple Dose Phase 2b Study of ARC-520
Mar 5, 2015 07:30AM Arrowhead Acquires Novartis’ RNAi Research and Development Portfolio
View More Recent Stories